Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous subcutaneous insulin infusion: Special needs for children.

Peter Adolfsson1,2, Ralph Ziegler3, Ragnar Hanas1,4

  • 1Sahlgrenska Academy, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.

Pediatric Diabetes
|April 21, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucose Monitoring and Control Testing in Patients with Type 1 or Type 2 diabetes.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same author

Cost-effectiveness of control-IQ automated insulin delivery in adults with type 1 diabetes in Sweden.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Advancing Early-Stage Type 1 Diabetes Care: Future Focused Pathways for Identification, Screening, Diagnosis, and Monitoring.

Diabetes, obesity & metabolism·2026
Same author

Therapy for Type 1 Diabetes.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same author

Continuous Glucose Monitoring in Insulin-Treated Type 2 Diabetes Mellitus in Sweden: A Scoping Review and Policy Landscape Analysis.

Diabetes technology & therapeutics·2026
Same author

[Requirements for continuous glucose monitoring].

Lakartidningen·2026

Insulin pumps for children with type 1 diabetes require specific features like low basal rates for safety and accuracy. Careful selection of devices is crucial for effective continuous subcutaneous insulin infusion (CSII) therapy.

Area of Science:

  • Pediatric Endocrinology
  • Biomedical Engineering

Background:

  • Continuous subcutaneous insulin infusion (CSII) is a primary treatment for pediatric type 1 diabetes.
  • Children have unique physiological needs impacting insulin pump requirements compared to adults.

Purpose of the Study:

  • To highlight the specific challenges and requirements of insulin pump therapy in children.
  • To emphasize the importance of selecting appropriate insulin pumps for pediatric CSII.

Main Methods:

  • Analysis of current insulin pump technology limitations for pediatric use.
  • Review of safety features and accuracy considerations for low basal rates.
  • Discussion of bolus advisor functionalities and connectivity.

Main Results:

Keywords:
bolus advisorcontinuous subcutaneous insulin infusioninsulin pump

Related Experiment Videos

  • Standard insulin pumps exhibit decreased accuracy at the very low basal rates required by children.
  • Limited lowest delivered amounts restrict fine-tuning and temporary basal rate options.
  • Delayed occlusion alarms at low basal rates increase the risk of hyperglycemia and diabetic ketoacidosis.

Conclusions:

  • Pediatric CSII requires insulin pumps with high accuracy at low basal rates and responsive safety features.
  • Bolus advisor settings and continuous glucose monitoring integration are vital for safe and effective therapy.
  • Thorough comparison of insulin pump features is essential for optimal pediatric diabetes management.